American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2009-10, Vol.115 (1), p.132-134
1. Verfasser:	Temin, Sarah
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Combined Chemotherapy Protocols - therapeutic use Aromatase Inhibitors - adverse effects Aromatase Inhibitors - therapeutic use Breast Neoplasms - prevention & control Female Fenretinide - adverse effects Fenretinide - therapeutic use Hematology, Oncology and Palliative Medicine Humans Obstetrics and Gynecology Raloxifene Hydrochloride - adverse effects Raloxifene Hydrochloride - therapeutic use Tamoxifen - adverse effects Tamoxifen - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!